St Johns Wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: Continuation data from a 26-week RCT

Pharmacopsychiatry

Volumn 45, Issue 7, 2012, Pages 275-278

  Sarris, J ^a,b   Fava, M ^c   Schweitzer, I ^a   Mischoulon, D ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

antidepressants; depression; herbal medicine; Hypericum perforatum; randomized controlled trial; sertraline; St Johns wort

Indexed keywords

HYPERICUM PERFORATUM EXTRACT; PLACEBO; SERTRALINE; ANTIDEPRESSANT AGENT; HYPERICUM EXTRACT LI 160; PLANT EXTRACT;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HAMILTON SCALE; HUMAN; HYPERICUM PERFORATUM; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE; CONTROLLED CLINICAL TRIAL; HYPERICUM; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; STATISTICS;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERICUM; MALE; MIDDLE AGED; PLACEBOS; PLANT EXTRACTS; PSYCHIATRIC STATUS RATING SCALES; SERTRALINE;

EID: 84869489260     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0032-1306348     Document Type: Article

References (16)

1. Muller W-E. Current St Johns wort research from mode of action to clinical efficacy. Pharmacol Res: 2003; 47 101 109
2. Sarris J., Panossian A., Schweitzer I. et al. Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol: 2011; in press
3. Kasper S., Gastpar M., Möller H. J. et al. Better tolerability of St. Johns wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression. Int Clin Psychopharmacol: 2010; 25 204 213
4. Linde K., Berner M., Kriston L. St Johns wort for major depression. Cochrane Database Syst Rev: 2008; 04 CD000448
5. Sarris J., Kavanagh D-J. Kava and St Johns wort: current evidence for use in mood and anxiety disorders. J Altern Complement Med: 2009; 15 827 836
6. Fava M., Alpert J., Nierenberg A. A. et al. A double-blind, randomized trial of St Johns wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol: 2005; 25 441 447
7. Shelton R-C, Keller M. B., Gelenberg A. et al. Effectiveness of St Johns wort in major depression: a randomized controlled trial. JAMA: 2001; 285 1978 1986
8. Hypericum Depression Trial Study Group Effect of Hypericum perforatum (St Johns wort) in major depressive disorder: a randomized controlled trial. JAMA: 2002; 287 1807 1814
9. Kasper S., Volz H. P., Möller H. J. et al. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression - a double-blind, randomized, placebo controlled long-term trial. Eur Neuropsychopharmacol: 2008; 18 803 813
10. Gastpar M., Singer A., Zeller K. Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline. Pharmacopsychiatry: 2005; 38 78 86
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry: 1960; 23 56 62
12. Beck A-T, Ward C., Mendelson M. Beck Depression Inventory (BDI). Arch Gen Psychiatry: 1961; 4 561 571
13. Endicott J., Spitzer R. L., Fleiss J. L. et al. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry: 1961; 33 766 771
14. Guy W., Bonato R-E. CGI: Clinical Global Impressions. Manual for the ECDEU Assessment Battery. 2. Rev ed. Chevy Chase, MD National Institute of Mental Health: 1970; (12-1-12-6)
15. Trivedi M-H, Fava M., Wisniewski S. R. et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med: 2006; 354 1243 1252
16. Fournier J., DeRubeis R. J., Hollon S. D. et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA: 2010; 303 47 53